Ghost Tree Capital »

89bio shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $463k 30k 15.44
2023-03-31 $4.6M 300k 15.23

More positions owned by Ghost Tree Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Sarepta Therapeutics (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Akero Therapeutics (AKRO)
Krystal Biotech (KRYS)
Madrigal Pharmaceuticals (MDGL)
Tg Therapeutics (TGTX)
Immunovant (IMVT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Axsome Therapeutics (AXSM)
Alpine Immune Sciences (ALPN)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Tarsus Pharmaceuticals (TARS)
Apellis Pharmaceuticals Call Option (APLS)

View all positions for Ghost Tree Capital

Top funds holding 89bio

RA Capital Management
Henderson Group
Vanguard Group
BVF
Holocene Advisors
Laurion Capital Management
Citadel Advisors
Frazier Life Sciences Management
Redmile Group
Federated Investors
Westfield Capital Management Company
Superstring Capital Management
Franklin Resources
Orchard Capital Managment
Caption Management

View all funds holding 89bio